Showing 511-520 of 765 results for "".
JAK Inhibitors in Hidradenitis Suppurativa: A Systematic Review
https://practicaldermatology.com/topics/feature/jak-inhibitors-in-hidradenitis-suppurativa-a-systematic-review/29887/Hidradenitis suppurativa (HS) is a chronic, disfiguring, debilitating, inflammatory disorder that is characterized by inflammatory nodules, abscesses, fistulae/ sinus tracts, and scarring to the axilla, inframammary folds, and groin.Therapeutics Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/theraputics-update/20510/New products and pharmacologic developmentsCosmeceuticals: Sunscreens
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-sunscreens/21366/What you should know about the FDA's final ruling on sunscreen products and tips for understanding the variety of sun protection ingredients available to make more informed recommendations to patients.Cannabinoid Photo-Rejuvenation: A Clinico-Pathologic Study
https://practicaldermatology.com/topics/feature/cannabinoid-photo-rejuvenation-a-clinico-pathologic-study/29188/In this study, we sought to assess the effectiveness of a novel topical formulation containing CBD isolate, resveratrol, thyme extract, caffeine, and lecithin in reversing photodamage over a 90-day treatment period.Racism in Medicine and the Problem of Health Care Disparities
https://practicaldermatology.com/topics/skin-of-color/racism-in-medicine-and-the-problem-of-health-care-disparities/23761/Dermatologists can work to improve health outcomes for all patients.Aesthetic Dermatology in 2021
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-dermatology-in-2021/23468/A look at how the COVID-19 pandemic has affected the demand for aesthetic procedures in dermatology offices around the country.Therapeutic Focus: Laser and Light Therapy
https://practicaldermatology.com/topics/general-topics/therapeutic-focus-laser-and-light-therapy/21384/New products and pharmacologic developments2019 In Review
https://practicaldermatology.com/topics/practice-management/2019-in-review/23168/A look back at approvals, data, and industry developments of the year.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.EGFR Inhibitor-induced Acneiform Rash: A Review of Current Management Strategies
https://practicaldermatology.com/topics/general-topics/egfr-inhibitor-induced-acneiform-rash-a-review-of-current-management-strategies/21517/